Clinical commissioning policy: Lonafarnib for Hutchinson-Gilford progeria syndrome (12 months of age and over)

Document first published:
Page updated:
Topic:
Publication type:

Lonafarnib is recommended to be available as a routine commissioning treatment option for Hutchinson-Gilford progeria syndrome (HGPS) within the criteria set out in this document.

Document

Clinical commissioning policy: Lonafarnib for Hutchinson-Gilford progeria syndrome (12 months of age and over)

Clinical commissioning policy: Lonafarnib for Hutchinson-Gilford progeria syndrome (12 months of age and over)

  • PDF
  • 222 KB
  • 8 pages

Summary

Published 16 July 2026.